News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingView Guidance
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, has reported a beneficial ownership of 3.56% in Rallybio Corporation's common stock as of June 30, 2026. This stake amounts to 188,422 shares, over which the group holds shared voting and shared …
CISO Global, Inc. (CISO) reported a narrower net loss for the quarter and first half ended June 30, 2026, due to significant cost controls and reduced interest expenses, despite a decline in revenue. However, the company faces substantial liquidity issues with a working capital …
Cormorant Asset Management, LP and Bihua Chen have reported that they no longer beneficially own any shares of Rallybio Corp (RLYB), marking their ownership at 0%. This disclosure, filed as an amendment to a Schedule 13G, indicates zero sole or shared voting or dispositive …
Sirenia Capital Management LP and Alex Silverstein have reported a beneficial ownership of 3,029,500 Common Shares in Cybin Inc., which includes 969,500 shares issuable upon the exercise of warrants. This stake represents 4.8% of Cybin's outstanding Common Shares, based on 61,984,078 shares as of …
Cybin Inc., doing business as Helus Pharma, has released its unaudited condensed interim consolidated financial statements for the first quarter ended June 30, 2026. The company reported a net loss of $47,819 thousand for the period, compared to a net loss of $24,613 thousand …
* Cybin press release [https://seekingalpha.com/pr/20619592-helus-pharma-reports-first-quarter-fiscal-2027-financial-results-and-recent-business] (HELP [https://seekingalpha.com/symbol/HELP]): Q1 Net loss was $47.8 million for the quarter ended June 30, 2026, compared to a net loss of $24.6 million in the same period last year. * Cash totaled $166.4 million as of June 30, 2026. …
Cybin, Inc. (CN:HELP) shares saw a significant 7.45% surge on August 12, 2026, driven by increased trading activity, though the exact catalyst remains unconfirmed. The clinical-stage biopharmaceutical company focuses on developing psychedelic-based therapies for mental health conditions like depression. Investors are advised to research …
Adage Capital Management, L.P. and associated parties have disclosed a 5.29% beneficial ownership in Cybin Inc. (HELP), totaling 3,289,250 common shares, which includes shares issuable from warrants. This ownership stake grants them shared voting and dispositive power over these shares. The filing, a Schedule …
Qiming GP VII, LLC and its affiliated funds have disclosed an updated beneficial ownership of 6.9% of Yuanbao Inc.'s (YB) Class A ordinary shares. This ownership includes holdings by Qiming Venture Partners VII, L.P. (6.8%) and Qiming VII Strategic Investors Fund, L.P. (0.1%), totaling …
Cybin Inc. (CN:HELP), a clinical-stage biotechnology company focused on psychedelic-based therapeutics for mental health, saw its shares decline by 14.05% on August 10, 2026, due to cautious investor sentiment in the emerging healthcare sector. The company's business model relies on R&D and clinical advancement, …
Helus Pharma (Cybin Inc.) CEO Michael Halstead will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, at 12:00 p.m. EDT. The clinical-stage pharmaceutical company is developing novel serotonergic agonists (NSAs) for mental health conditions, including …
Helus Pharma (Nasdaq: HELP) will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11-12, 2026. CEO Michael Halstead is scheduled to present in a fireside chat on Wednesday, August 12, at 12:00 p.m. EDT. The company, known for developing …
This article highlights several technology and growth companies, including Archer Aviation (ACHR), ImmunityBio (IBRX), Sphere 3D Corp. (ANY), Graphene Manufacturing Group (GMG), and Socket Mobile (SCKT), which are attracting investor attention due to recent corporate, technology, and strategic developments. Archer Aviation is expanding its …
Cybin Inc. (CN:HELP) shares dropped by 10.54% due to investor caution surrounding psychedelic medicine, regulatory uncertainties, and the inherent volatility of clinical-stage biotechnology companies. The company develops psychedelic-based therapies for mental health, but its valuation is highly dependent on successful clinical trials, regulatory approvals, …
ImmunityBio, Inc. (NASDAQ:IBRX) has announced the appointment of Dr. Jim Yong Kim as vice chairman, who will focus on international partnerships and global access initiatives within the newly created Office of the Executive Chairman. Dr. Kim, a former president of the World Bank Group …
This article provides a technical analysis of Yuanbao Inc (YB), detailing its current price momentum score of 2.86 within the Insurance industry and noting its trading range between resistance at $14.36 and support at $13.10. It presents an overview of various technical indicators and …
Rallybio Corp (RLYB) has an earnings forecast score of 6.00, placing it 330 out of 387 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $1.00 for RLYB, with recent EPS at -$1.03 against an expectation of -$1.46. …
This article provides an earnings forecast for CISO Global Inc (CISO), including future EPS and revenue growth estimates. It notes the company's current stock price, market cap, and P/E ratio, along with a list of peer companies for comparison. The financial data was updated …
Search by ticker symbol or company name and select a result to open its chart.